We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Retinoic Acid Prevents Precancerous Breast Cells from Progressing to Full-Blown Cancer

By LabMedica International staff writers
Posted on 20 Apr 2014
Print article
Retinoic acid, a derivative of vitamin A, was found to prevent pre-cancerous breast cells from progressing to full-blown cancer but did not have any effect on breast tumor cells.

Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with a novel breast cancer model that had been developed by treating MCF-10F human normal breast epithelial cells with a high dose of estradiol. The model system consisted of four distinct cell lines which demonstrated a progressive neoplastic transformation: MCF-10F, normal stage; trMCF, transformed MCF-10F; bsMCF, invasive stage; and caMCF, tumorigenic stage. In three-dimensional cultures, MCF-10F cells formed tubules resembling the structures in the normal mammary gland. After treatment with estradiol, these cells formed tubules and spherical masses which were indicative of transformation.

In the current study the investigators evaluated the effect of all trans-retinoic acid (ATRA) at different stages of neoplastic transformation. Retinoids have been used as potential chemotherapeutic or chemopreventive agents because of their differentiative, antiproliferative, proapoptotic, and antioxidant properties.

Cells that only formed spherical masses in collagen were isolated (trMCF clone 11) and treated with ATRA. After treatment with a concentration of one micromolar ATRA, the trMCF clone 11 cells showed tubules in collagen. Gene expression studies showed that 207 genes upregulated in transformed trMCF clone 11 cells were downregulated after one micromolar ATRA treatment to levels comparable to those found in the normal breast epithelial cells MCF-10F. Furthermore, 236 genes that were downregulated in trMCF clone 11 were upregulated after one micromolar ATRA treatment to similar levels shown in normal epithelial cells. These 443 genes defined a signature of the ATRA reprogramming effect.

Results published in the March 21, 2014, edition of the International Journal of Oncology showed that one micromolar ATRA was able to re-differentiate transformed cells at early stages of the neoplastic process and antagonistically regulate breast cancer associated genes. On the other hand, the invasive and tumorigenic cells did not show any changes in morphology after ATRA treatment.

“It looks like retinoic acid exerts effects on cancer cells in part via the modulation of the epigenome,” said senior author Dr. Sandra V. Fernandez, assistant research professor of medical oncology at Thomas Jefferson University. “We were able to see this effect of retinoic acid because we were looking at four distinct stages of breast cancer. It will be interesting to see if these results can be applied to patients.”

Related Links:

Thomas Jefferson University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.